Fenbendazole is a benzimidazole that presents a wide spectrum anthelmintic effect against parasitic protozoa, worms and nematodes. It is also used as an anticancer drug. It destroys microtubules that cancer cells use to grow and divide. It boosts production of a gene called p53 that can kill cancer cells. It blocks sugar absorption in cancer cells, which starves them of the energy they need to survive.
In the laboratory, fenbendazole is known to have both cytotoxic and cytostatic effects when used at high concentrations and long incubations. This molecule is thought to interact with the -tubulin dimers found in parasite cells, and it inhibits the polymerization of tubulin into microtubules that cancer cells use. This causes the cell to destabilize and die.
The sanare lab fenbendazole is a very powerful anti-cancer agent. It can kill tumors of all types, including brain and colon cancer. It also helps prevent the growth of new blood vessels that feed tumors, and it reduces tumor size by preventing their vascular supply. It also appears to block inflammatory pathways that cause the cell to become more prone to apoptosis. In a series of experiments, researchers discovered that higher doses of fenbendazole had a more significant cytotoxic effect than lower ones.
Scientists were able to confirm these results by rigorously comparing tumor growth between different treatment groups. The mice were randomly assigned to receive either no fenbendazole, low doses of fenbendazole or high doses of fenbendazole. Tumors were injected into the mice, and after they reached a certain volume, they were euthanized and necropsied. The scientists were able to determine that the number of lung metastases in mice treated with fenbendazole did not increase after irradiation, compared to untreated mice.
This is an extremely important discovery for people suffering from a variety of cancers, and for all those fighting to stop the pharmaceutical companies from keeping such life saving drugs out of their hands. There is also evidence that fenbendazole can prevent the growth of hydatid cysts, which are often the source of cyathostome disease.
sanare lab fenbendazole Dosage
In humans, fenbendazole is well-tolerated at doses up to 222 mg/day. It is prescribed for the treatment of cystic hydatid disease in animals, and it is used to control encysted early third stage, late third and fourth stage cyathostome larvae and Strongylus vulgaris fourth stage cyathostome larves in poultry. It is marketed under the trade name Panacur C and is available in powder and capsule form.
For the control of encysted early third stage (hypobiotic) and late third and fourth stage cyathostome larves of poultry and zoo and wild birds, it is administered orally at a dosage of 10 mg/kg body weight twice daily for a period of four days followed by two days off, in accordance with recommended labeling instructions. The drug is also indicated for the treatment and control of roundworms, including encysted early third stage and late third stage cyathostome larvae of cattle, sheep, goats, swine and turkeys, as well as for the control of hookworms, including Necator americanus and Heterostrongylus taurus, in dogs, cats and ferrets.